Invirion and Molecular expand HPV (human papillomavirus) licence
This article was originally published in Clinica
Executive Summary
Invirion and Molecular Diagnostics have expanded their licensing agreement covering Invirion's intracellular E6 and E7 detection of human papillomavirus (HPV). The new, exclusive, long-term agreement covers non-fluorescence-based applications, in addition to fluorescence applications covered under the original deal.